DJIA 18,175.67 134.13 0.74%
NASDAQ 5,108.72 75.97 1.51%
S&P 500 2,123.48 19.28 0.92%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.74 0.75 (1.12%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $67.74 1.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.33
Previous Close $66.99
Daily Range $66.61 - $67.88
52-Week Range $26.57 - $77.80
Market Cap $8.1B
P/E Ratio -334.95
Dividend (Yield) $0.00 (0.0%)
Volume 1,131,170
Average Daily Volume 2,293,719
Current FY EPS -$0.37




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

IWM, VGLT: Big ETF Inflows

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Just What Is Invested Capital Anyway?


4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development

Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio

See More ISIS News...

ISIS's Top Competitors

ISIS $67.74 (1.12%)
Current stock: ISIS
AMGN $160.51 (0.94%)
Current stock: AMGN
GILD $112.45 (2.44%)
Current stock: GILD
BIIB $403.10 (2.60%)
Current stock: BIIB